Results 171 to 180 of about 392,664 (239)

Do patients with migraine and obesity receive different treatments? Insights from real‐world data

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Background Patients with obesity often experience stigma in healthcare, which may lead to underdiagnosis or undertreatment. In the context of pain management, and migraine specifically, patients with obesity are more likely to receive both opioid and non‐opioid analgesics.
Keshet Pardo   +3 more
wiley   +1 more source

Routes of postoperative analgesia administration in surgical wards: practice vs. guidelines and economic implications. [PDF]

open access: yesFront Med (Lausanne)
Bojic S   +9 more
europepmc   +1 more source

Opioid Crisis: No Easy Fix to Its Social and Economic Determinants.

open access: yesAmerican Journal of Public Health, 2018
N. Dasgupta, L. Beletsky, D. Ciccarone
semanticscholar   +1 more source

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME (US) study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This study was undertaken to evaluate patient reasons for nonadoption of migraine‐preventive medications. Despite clear recommendations and eligibility criteria for migraine‐preventive treatment by the American Headache Society and the availability of these treatments, many people with migraine are not taking appropriate ...
Jessica Ailani   +9 more
wiley   +1 more source

Factors Associated with the Variation in Drug Prescription of Analgesics in Long-Term Care Facilities: A Systematic Review. [PDF]

open access: yesJ Clin Med
Bibi R   +7 more
europepmc   +1 more source

A retrospective audit of the real‐world safety and effectiveness profile of eptinezumab for treatment‐resistant chronic migraine in Australia

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To describe the real‐world safety, tolerability, and effectiveness of eptinezumab for chronic migraine prevention in Australia. Background Eptinezumab is a relatively new medication for treatment‐resistant chronic migraine prevention.
Lakshini Gunasekera   +7 more
wiley   +1 more source

Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014

open access: yesAmerican Journal of Public Health, 2018
Jon E. Zibbell   +6 more
semanticscholar   +1 more source

Polypharmacy in HIV: Rethinking what counts and why it matters

open access: yesHIV Medicine, EarlyView.
Abstract Polypharmacy, the concurrent use of multiple medications, presents a growing challenge in HIV care as people living with HIV age and experience earlier onset of age‐related co‐morbidities. However, how polypharmacy is defined and assessed in HIV research remains inconsistent.
Luxsena Sukumaran   +6 more
wiley   +1 more source

Natural‐based antioxidants in cosmeceuticals: Extraction, bioavailability and skin ageing applications

open access: yesInternational Journal of Cosmetic Science, EarlyView.
Natural antioxidants from plants, fruits, seeds and fungi combat ageing by neutralizing free radicals, boosting collagen and protecting against UV damage. Enhanced by green extraction and smart delivery systems, they offer powerful anti‐inflammatory and antimicrobial benefits.
Hossein Omidian   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy